Pharmaceutical Technology

JANUARY 23, 2023

Therefore, with an inadequate or loss of response to these anti-TNFs, clinicians must prescribe adult therapies off-label to treat younger patients. These developments were compounded by Lilly’s announcement that it has discontinued development of mirikizumab for psoriasis in April of last year. Ther Innov Regul Sci.

Labelling 59

Labelling Compounding Drug Development 59

pharmaphorum

DECEMBER 5, 2022

Pluvicto becomes the first PSMA-targeted intravenous radioligand therapy – combining a targeting compound or ligand with a therapeutic radionuclide or radioactive particle (in this case, lutetium-177) – to demonstrate clinical benefit in mCRPC patients before receiving taxane-based chemotherapy.

Chemotherapy 59

Chemotherapy Labelling Compounding Drug Development 59

European Pharmaceutical Review

JULY 4, 2024

In the US, botanical dietary supplements can be sold without US Food and Drug Administration (FDA) approval, 1 prompting many vendors to promote the use of botanical products as dietary supplements , 2 rather than pursue a path of regulatory approval. The worldwide trend of using botanical drugs and strategies for developing global drugs.

Drug Development 103

Drug Development Biosimilars Documentation Labelling 103

Pulses

AUGUST 31, 2023

References Ley D, Parkes D, Walton G. 6-emerging technologies for learning.

Medication Dispensing 78

Medication Dispensing Medication Labelling Packaging Labelling 78

ID Stewardship

JUNE 6, 2023

Streamlined Prescription Filling : AI systems can automate prescription filling processes by extracting relevant information from electronic prescriptions, verifying insurance coverage, and generating labels. This reduces manual errors, saves time, and allows pharmacists to focus on patient care.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Prescription Filling Hospitals Medication Dispensing 52

European Pharmaceutical Review

JULY 5, 2022

The availability of oral chemotherapy treatments would provide stomach cancer patients with the option of more efficacious drugs with improved tolerability in a more convenient dosage format” The poor clinical outcomes of stomach cancer make it a key target for drug development. About the author. About the author.

Chemotherapy 104

Chemotherapy Dosage Labelling Compounding 104

Express Pharma

NOVEMBER 1, 2024

In the marathon of drug development, where billions of dollars and over a decade of research are the norm, drug repurposing is quietly reshaping the landscape. Evolving regulatory frameworks: One of the biggest hurdles is navigating the complex regulatory landscape that governs clinical drug development.

Drug Development 111

Drug Development Compounding Generic Medicine Vaccines 111